Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex in Peripheral Neuropathic Pain with Allodynia
NCT00710554Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Aug 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in Peripheral neuropathic pain, sponsored by Jazz Pharmaceuticals plc. Started Aug 2005; status: completed.
02
Drugs
cannabidiol
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT00710554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710554.